Rituximab for the treatment of type B insulin resistance syndrome: a case report and review of the literature.

Ken IseriM IyodaY ShikidaT InokuchiT MorikawaN HaraT HiranoT Shibata

Published in: Diabetic medicine : a journal of the British Diabetic Association (2018)

According to a literature review of 11 cases in addition to the present case, rituximab appears to be a safe and effective strategy for the treatment of corticosteroid-resistant type B insulin resistance syndrome.

Keyphrases

insulin resistance
case report
diffuse large b cell lymphoma
adipose tissue
metabolic syndrome
polycystic ovary syndrome
hodgkin lymphoma
combination therapy
high fat diet induced
glycemic control